Received Oct 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 93H32 | — |
Kinrix inadvertent administration; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 7-month-old patient who received DTPa-IPV (Kinrix) (batch number 93H32, expiry date 19-OCT-2026) for prophylaxis. Co-suspect products included Pentacel for prophylaxis. On 30-SEP-2025, the patient received Kinrix. The patient did not receive Pentacel. On 30-SEP-2025, an unknown time after receiving Kinrix, the patient experienced wrong vaccine administered (Verbatim: Kinrix inadvertent administration). The outcome of the wrong vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 03-OCT-2025 Health care provider wanted to know how to proceed with the patient that inadvertently received Kinrix instead of Pentacel it was third dose in the DTaP series. This case is linked with case US2025127285, reported by the same reporter.; Sender's Comments: US-GSK-US2025127285: